Navigation Links
Olivier Voinnet awarded 2009 EMBO Gold Medal
Date:4/22/2009

Heidelberg, Germany, 22 April 2009 - Olivier Voinnet from the CNRS Institute of Plant Molecular Biology in Strasbourg, France, is awarded the 2009 EMBO Gold Medal. The researcher receives this medal for his pioneering work on the mechanisms and roles of gene silencing via RNA in plants.

With this annual award, the European Molecular Biology Organization (EMBO) recognizes the outstanding contributions of young researchers in the molecular life sciences. The EMBO Gold Medal is widely regarded as one of the most prestigious life sciences awards in Europe, highlighting the high standards of Europe's best scientists.

"Olivier Voinnet's contributions to our understanding of gene silencing via RNA have opened up new perspectives on how the activity of genes may be controlled," said Hermann Bujard, EMBO Director. "His outstanding work reflects imaginative approaches and a broad understanding of biological processes."

The prizewinner conducts fundamental biological research with significant implications for medicine. RNA silencing is a newly discovered and highly competitive field in molecular biology. It describes a gene regulation process that has implications for the maintenance of genome integrity, antiviral defense, and developmental patterning in many organisms. Defects in these processes can result in major human diseases including cancer.

"Olivier Voinnet is one of the most extraordinary young scientists that I have encountered," writes David Baulcombe, Professor of Botany at the Department of Plant Sciences, University of Cambridge, UK.

Already during his predoc time at Baulcombe's lab from 1996 to 2001, Voinnet's discoveries laid the foundation for his later understanding of the way plants use silencing to defend themselves against viruses, and how viruses, in turn, counteract this defense. "We did not know anything about the microRNAs or small interfering RNAs at that time," says the biologist. "Yet, with David, w
'/>"/>

Contact: Suzanne Beveridge
beveridge@embo.org
49-622-188-91108
European Molecular Biology Organization
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. INDUS Corporation Awarded Army Office of the Surgeon General Contract
2. HMS Awarded Medicaid Provider Audit Contract in Virginia
3. Three Medical Centers Awarded Funds to Study Generation of Cardiac Muscle Cells
4. HMS Awarded Medicaid Audit Contract in South Carolina
5. Companion Benefit Alternatives Awarded Silver Honors for Best Practices in Health Plans and Health Networks by URAC
6. Health and Wellness Partners, Inc., a Wholly Owned Subsidiary of Zealous Inc., is Awarded the Exclusive California Distribution Rights for RockHard Weekend!!!
7. Harris Corporation Awarded Follow-on Contract Option to Expand CONNECT Solution for Nationwide Health Information Network
8. Isis Scientist Awarded 2009 Ebert Prize
9. Harris Corporation Awarded $14 Million Contract to Develop Multi-Hospital Military Health System Network with Image-Sharing Capabilities
10. Nonin Medical Awarded a Premier Contract for Its Innovative Oximetry Solutions
11. Hahnemann University Hospital Awarded Certification From the Joint Commission for Ventricular Assist Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... West Hollywood, CA (PRWEB) May 22, 2015 ... at Sunset Plaza Dental announces that they ... in cosmetic, restorative and other dental treatments. At ... that interest them. Questions regarding what certain treatments ... can also be covered during this initial appointment. ...
(Date:5/22/2015)... 22, 2015 Medivo, Inc., a leader in ... and Genotype Results in ‘Baby Boomers’ Screened for HCV Following ... Lab Test Database” at Digestive Disease Week, May 16-19, 2015. ... and Analytics team members Carol Smyth, MB; Jason Bhan, MD; ... MSI, along with Nancy Reau, MD from the University of ...
(Date:5/22/2015)... 2015 A Phase 3 French ... Society of Clinical Oncology (ASCO)’s annual meeting at ... for those patients who received bevacizumab in addition ... Bevacizumab (Avastin® Genentech, Inc.) is an antibody that ... already routinely used to treat many other cancers, ...
(Date:5/22/2015)... Jupiter, FL (PRWEB) May 22, 2015 ... Ed Begley, Jr., scheduled to broadcast on Friday, May ... PST, via Discovery Channel. , In this episode Innovations ... companies get back to business quickly through disaster recovery ... NDPTC, a company that works collaboratively to develop and ...
(Date:5/22/2015)... AZ (PRWEB) May 22, 2015 In ... Olympics, Parker and Sons is offering to donate $5 ... installing an AC unit or water softening system. Customers ... behalf; Parker and Sons gets business; and the Special ... , The Special Olympics helps over 4.4 million athletes, ...
Breaking Medicine News(10 mins):Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2
... Under the scheme 'Assistance for capacity Building', Ministry ... upto a maximum //of Rs. 1.50 crores or ... of emergency facilities of State Hospitals of towns/cities ... with NHAI, Department of Road Transport and Highways ...
... new study by specialists at the Johns Hopkins Children’s ... inner-city children with chronic asthma //gets enough medicine to ... reported in December's Pediatrics, are disturbing, the researchers say, ... 'rescue' drugs after an asthma attack strikes and to ...
... women in Scotland wait for weeks to find out if ... of the Scotland's screening //services in meeting the basic deadlines ... east of Scotland, where one quarter of those tested did ... covering Tayside and Fife admitted the delay as a usual ...
... American Dental association announced on the 9th of November, urging ... of infant formulation. // ,The dentists are concerned about ... be disastrous as instead of protecting teeth it might permanently ... to weakened bones and even bone cancer boys. ,This ...
... scientists to exploit prevailing drugs, already in use ... impeding cognitive //decline in Alzheimer's disease, has borne ... of scientists' attention, offers promise in its perceived ... a foregone conclusion for patients afflicted with Alzheimer's. ...
... Innovation and Improvement suggested that some patients should be cared ... admitting them in the hospital wards. ,The ... Accident and Emergency (A&E) departments that leads to hospital admissions ... numbers admitted in hospital wards. ,Home ...
Cached Medicine News:Health News:City Kids With Asthma Lose Out on Preventive Treatment 2Health News:Scotland Women Wait For Weeks For Getting Breast Cancer Results 2
(Date:5/22/2015)... Md. , May 22, 2015  RegeneRx ... today announced a peer-reviewed publication of the results ... evaluating RGN-259 (RegeneRx,s preservative-free eye drops) for the ... controlled adverse environment (CAE ® ) model.  The ... the results, which were previously disseminated by the ...
(Date:5/22/2015)... BOSTON , May 22, 2015   InspireMD, Inc. ... in stent embolic protection systems ("EPS"), today announced that its ... PARADIGM, lead by principle investigator Prof. Piotr Musialek , ... in Paris, France . PARADIGM, ... pe R cutaneous c A roti D revascularization ...
(Date:5/22/2015)... , May 22, 2015 ... phase clinical research unit with a worldwide reputation ... for its frequent publications in peer reviewed medical ... European stakeholders and regulators in discussions about rules ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , ...
Breaking Medicine Technology:Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4
... Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ... offering of senior notes. The Company intends ... a substantial portion of the outstanding borrowings under its credit ... Pierce, Fenner & Smith Incorporated, BNP Paribas Securities Corp. and ...
... 70,737 patients through institutional databases and medical charts, researchers ... determined that only 20 percent of patients with newly ... factors were screened for HBV infection before starting chemotherapy. ... P. Hwang, MD, MPH, the lead author of the ...
Cached Medicine Technology:Zimmer Holdings, Inc. Announces Offering of Senior Notes 2Patients at Risk for Hepatitis B Are Not Adequately Screened Before Receiving Chemotherapy Leading to the Preventable Reactivation of Hepatitis B Infection 2